Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
United Therapeutics Corporation June 26, 202698.5%
-
Ares Management Corporation June 8, 202692.4%
-
Mattel Inc. May 28, 202692.6%
-
United Therapeutics Corporation June 26, 202599.1%
-
Ares Management Corporation June 6, 202594.5%
-
Mattel Inc. May 28, 202598.8%
-
United Therapeutics Corporation June 26, 202499.2%
-
Ares Management Corporation June 4, 202493.5%
-
Mattel Inc. May 29, 202498.6%
-
United Therapeutics Corporation June 26, 202396.0%
-
Ares Management Corporation June 12, 202394.3%
-
Mattel Inc. May 15, 202399.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 30, 2026 | Ares Management Corporation | Grant or award | +1,728 | — | — |
| Jul 9, 2026 | United Therapeutics Corporation | Option exercise | +1,310 | — | — |
| May 15, 2026 | Mattel Inc. | Option exercise | +8,594 | — | — |
| Mar 23, 2026 | United Therapeutics Corporation | Open-market sale | −200 | $530.00 | $106,000 |
| Mar 16, 2026 | United Therapeutics Corporation | Open-market sale | −200 | $535.44 | $107,088 |
| Mar 6, 2026 | United Therapeutics Corporation | Open-market sale | −200 | $510.00 | $102,000 |
| Feb 27, 2026 | United Therapeutics Corporation | Open-market sale | −200 | $509.55 | $101,910 |
| Feb 20, 2026 | Ares Management Corporation | Open-market purchase | +480 | $124.43 | $59,726 |
| Sep 19, 2025 | United Therapeutics Corporation | Open-market sale | −1,800 | $415.43 | $747,774 |
| Jul 31, 2025 | Ares Management Corporation | Grant or award | +1,166 | — | — |
| Jul 25, 2025 | United Therapeutics Corporation | Option exercise | +1,190 | — | — |
| May 23, 2025 | Mattel Inc. | Option exercise | +6,843 | — | — |
| Dec 12, 2024 | Ares Management Corporation | Gift | −397 | — | — |
| Nov 11, 2024 | United Therapeutics Corporation | Open-market sale | −1,750 | $412.48 | $721,840 |
| Sep 17, 2024 | United Therapeutics Corporation | Option exercise | +2,300 | $112.14 | $257,922 |
Questions about Judy D. Olian
What boards is Judy D. Olian on?
Judy D. Olian sits on the boards of Ares Management Corporation, Mattel Inc. and United Therapeutics Corporation.
How long has Judy D. Olian served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.